Stockholders' Equity

3 Months Ended

Mar. 30, 2025

Stockholders' Equity Note [Abstract]

Stockholders' Equity

Note 9. Stockholders’ Equity

Stock Repurchases

From time to time, the Company’s Board of Directors has authorized programs under which the Company may repurchase shares of its common stock, depending on market conditions, in the open market or through privately negotiated transactions. Under the authorizations, the timing and actual number of shares subject to repurchase are at the discretion of management and are contingent on a number of factors, such as levels of cash generation from operations, cash requirements for acquisitions and the price of the Company’s common stock. During the three months ended March 30, 2025 and March 31, 2024, the Company repurchased, retired and reported, based on trade date, approximately 0.3 million and 0.8 million shares of common stock, at a cost of approximately $7.5 million and $11.4 million, respectively. As of March 30, 2025, approximately 3.1 million shares remained authorized for repurchase under the repurchase program.

The Company repurchased and reported, based on trade date, approximately 186,000 shares and 32,000 shares of common stock, at a cost of approximately $5.1 million and $0.5 million, during the three months ended March 30, 2025 and March 31, 2024, respectively, to administratively facilitate the withholding and subsequent remittance of personal income and payroll taxes for individuals receiving RSUs.

These shares were retired upon repurchase. The Company’s policy related to repurchases of its common stock is to charge the excess of cost over par value to retained earnings. All repurchases were made in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended.

Accumulated Other Comprehensive Income (Loss)

The following tables set forth the changes in accumulated other comprehensive income (loss) (“AOCI”) by component:

(In thousands)	Unrealized gains (losses) on available -for-sale investments			Unrealized gains (losses) on derivatives			Estimated tax benefit (provision)			Total
Balance as of December 31, 2024	$	169		$	79		$	(7	)	$	241
Other comprehensive income (loss) before reclassifications		(78	)		(662	)		115			(625	)
Less: Amount reclassified from accumulated other comprehensive (loss) income		—			(382	)		80			(302	)
Net current period other comprehensive income (loss)		(78	)		(280	)		35			(323	)
Balance as of March 30, 2025	$	91		$	(201	)	$	28		$	(82	)
(In thousands)	Unrealized gains (losses) on available -for-sale investments			Unrealized gains (losses) on derivatives			Estimated tax benefit (provision)			Total
Balance as of December 31, 2023	$	126		$	7		$	3		$	136
Other comprehensive income (loss) before reclassifications		(166	)		(5	)		6			(165	)
Less: Amount reclassified from accumulated other comprehensive income (loss)		—			(63	)		13			(50	)
Net current period other comprehensive income (loss)		(166	)		58			(7	)		(115	)
Balance as of March 31, 2024	$	(40	)	$	65		$	(4	)	$	21

The following table provides details about significant amounts reclassified out of each component of AOCI:

	Three Months Ended
(In thousands)	March 30, 2025			March 31, 2024
Amount Reclassified from AOCI
Gains (losses) on cash flow hedge:
Foreign currency forward contracts
Affected line item in the statement of operations
Net revenue	$	(522	)	$	(79	)
Cost of revenue		—			—
Research and development		32			(1	)
Sales and marketing		79			9
General and administrative		29			8
Total before tax		(382	)		(63	)
Tax impact		80			13
Total, net of tax	$	(302	)	$	(50	)